Cargando…
CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients
The CC chemokine receptor 5 (CCR5) delta 32 allele results in a nonfunctional form of the chemokine receptor and has been implicated in a variety of immune-mediated diseases. CCR5Δ32 may also predispose one to chronic liver disease or be linked with resistance to HBV infection. This study was undert...
Autores principales: | Abdolmohammadi, Reza, Azar, Saleh Shahbazi, Khosravi, Ayyoob, Shahbazi, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454610/ https://www.ncbi.nlm.nih.gov/pubmed/27892677 http://dx.doi.org/10.22034/APJCP.2016.17.10.4643 |
Ejemplares similares
-
Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population
por: Gholizadeh, Mehdi, et al.
Publicado: (2017) -
The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular
Carcinoma in an Iranian Population
por: Bazgir, Afsaneh, et al.
Publicado: (2018) -
Interferon Gamma Gene Polymorphism (+874 T > A) and Chronic Hepatitis B in the Population of Gorgan, North-Eastern Iran
por: Ghasemian, Nadia, et al.
Publicado: (2016) -
3-Dimensional Model to Study Apoptosis Induction of Activated Natural Killer Cells Conditioned Medium Using Patient-Derived Colorectal Cancer Organoids
por: Parseh, Benyamin, et al.
Publicado: (2022) -
The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations
por: Zare-Bidaki, Mohammad, et al.
Publicado: (2015)